Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q1 2022
- Shares held
- 6.93M
- −1.15M (−14.3%) vs. Q1 2022
- Total value
- $2.08M
- −$4.46M (−68.2%) vs. Q1 2022
- New holders
- 5
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gofen & Glossberg LLC | 3,819,170 | $1.15M | 0.03% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,597,049 | $479.0K | 0.01% | −422,946−20.9% | Reduced |
| BlackRock Inc. | 479,065 | $144.0K | 0.00% | −31,653−6.2% | Reduced |
| Vanguard Group Inc | 358,978 | $108.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 200,000 | $60.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 138,407 | $42.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 72,900 | $22.0K | 0.00% | +72,900 | New |
| Renaissance Technologies LLC | 66,232 | $20.0K | 0.00% | −1,200−1.8% | Reduced |
| Financial Advisory Service, Inc. | 58,326 | $17.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 51,212 | $15.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 34,671 | $10.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 18,980 | $6.00K | 0.00% | +18,980 | New |
| Citigroup Inc | 13,500 | $4.00K | 0.00% | +13,500 | New |
| Tower Research Capital LLC (TRC) | 9,628 | $3.00K | 0.00% | +4,806+99.7% | Added |
| Millennium Management LLC | 10,784 | $3.00K | 0.00% | +10,784 | New |
| Banque Cantonale Vaudoise | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $0 | 0.00% | +8+8.7% | Added |
| Umb Bank N A | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Horan Securities, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Planning LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 100 | $0 | 0.00% | +100 | New |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −735,097−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −71,808−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,658−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2−100.0% | Sold out |